Stock Research: Abbott Laboratories

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Abbott Laboratories

NYQ:ABT US0028241000
95
  • Value
    92
  • Growth
    31
  • Safety
    Safety
    68
  • Combined
    88
  • Sentiment
    91
  • 360° View
    360° View
    95
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad line of healthcare products. It operates in the Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices industries. The company serves people in over 160 countries. In the last fiscal year, the company had a market cap of $228,771 million, profits of $23,306 million, and revenue of $41,950 million with 114000 employees.

more
Index
D.J. US Health Care
D.J. US Medical Equipment
S&P 500
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 59 62 87
Growth
31 55 49 45
Safety
Safety
68 81 42 30
Sentiment
91 90 83 95
360° View
360° View
95 98 86 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
58 69 62 64
Opinions Change
50 49 48 50
Pro Holdings
n/a 96 83 97
Market Pulse
94 97 78 78
Sentiment
91 90 83 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
92 59 62 87
Growth
31 55 49 45
Safety Safety
68 81 42 30
Combined
88 91 56 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
52 33 35 51
Price vs. Earnings (P/E)
65 35 44 54
Price vs. Book (P/B)
56 35 31 43
Dividend Yield
100 96 98 98
Value
92 59 62 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
29 45 17 7
Profit Growth
50 49 30 70
Capital Growth
49 42 73 36
Stock Returns
41 69 67 81
Growth
31 55 49 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
62 58 44 41
Refinancing
14 17 9 3
Liquidity
87 95 86 76
Safety Safety
68 81 42 30

Similar Stocks

Discover high‑ranked alternatives to Abbott Laboratories and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: